We are live on ! Find out more
AGM

Alpine Global Management Portfolio holdings

AUM $668M
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+10.73%
1 Year Est. Return
+20.22%
3 Year Est. Return
+100.14%
5 Year Est. Return
+103.13%
10 Year Est. Return
+677.44%
AUM
$469M
AUM Growth
+$78.5M
Cap. Flow
+$57.8M
Cap. Flow %
12.33%
Top 10 Hldgs %
32.91%
Holding
466
New
384
Increased
10
Reduced
12
Closed
53

Sector Composition

Rank Sector Weight
1 Technology 23.5%
2 Healthcare 19.1%
3 Communication Services 10.87%
4 Industrials 10.09%
5 Consumer Discretionary 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAGE
176
DELISTED
Sage Therapeutics
SAGE
$453K 0.1%
+6,277
New +$772K
IONS icon
177
Ionis Pharmaceuticals
IONS
$9.35B
$452K 0.1%
+7,474
New +$445K
OCFC icon
178
OceanFirst Financial
OCFC
$1.7B
$452K 0.1%
+17,680
New +$425K
ALEC icon
179
Alector
ALEC
$164M
$447K 0.1%
+25,947
New +$441K
PBYI icon
180
Puma Biotechnology
PBYI
$406M
$447K 0.1%
+51,060
New +$423K
SDY icon
181
State Street SPDR S&P Dividend ETF
SDY
$21.9B
$441K 0.09%
+4,101
New +$430K
SBGI icon
182
Sinclair Inc
SBGI
$974M
$439K 0.09%
+13,168
New +$490K
MRNA icon
183
Moderna
MRNA
$21.5B
$434K 0.09%
+22,175
New +$393K
TWLO icon
184
Twilio
TWLO
$29.1B
$430K 0.09%
+4,379
New +$447K
TLRY icon
185
Tilray
TLRY
$479M
$428K 0.09%
+2,500
New +$517K
XBI icon
186
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$428K 0.09%
4,499
-1,379
-23% -$119K
MDB icon
187
MongoDB
MDB
$24B
$421K 0.09%
+3,198
New +$420K
GTHX
188
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$417K 0.09%
+15,760
New +$369K
IFF icon
189
International Flavors & Fragrances
IFF
$19.4B
$412K 0.09%
+3,195
New +$408K
CHPMU
190
DELISTED
CHP Merger Corp. Unit
CHPMU
$407K 0.09%
+40,000
New +$404K
SABA
191
Saba Capital Income & Opportunities Fund II
SABA
$220M
$397K 0.08%
+32,420
New +$391K
JQC icon
192
Nuveen Credit Strategies Income Fund
JQC
$702M
$387K 0.08%
+50,405
New +$374K
GDV icon
193
Gabelli Dividend & Income Trust
GDV
$2.6B
$385K 0.08%
+17,525
New +$367K
CLVS
194
DELISTED
Clovis Oncology, Inc.
CLVS
$385K 0.08%
+36,924
New +$269K
VYGR icon
195
Voyager Therapeutics
VYGR
$187M
$383K 0.08%
+27,452
New +$399K
ACNB icon
196
ACNB Corp
ACNB
$634M
$378K 0.08%
+10,000
New +$353K
DRRX
197
DELISTED
DURECT Corp
DRRX
$371K 0.08%
+9,768
New +$201K
FXL icon
198
First Trust Technology AlphaDEX Fund
FXL
$2.47B
$365K 0.08%
+5,027
New +$345K
SRC
199
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
$358K 0.08%
+7,289
New +$363K
QVCGA
200
DELISTED
QVC Group Inc Series A
QVCGA
$355K 0.08%
+866
New +$390K

Similar funds

Alpine Global Management's Q4 2019 Portfolio in Review

As of Q4 2019, Alpine Global Management held 466 positions worth $469M, up 20% from $390M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Alpine Global Management deployed $57.8M of net new capital in Q4 2019, opening 384 new positions and adding to 10 existing holdings. Its largest new stake was Shockwave Medical, Inc. Common Stock: 724,857 shares worth $31.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Block Inc, an estimated $19M trimmed.

  • Alpine Global Management's largest Q4 2019 buy was Shockwave Medical, Inc. Common Stock: 724,857 shares worth $31.8M.
  • Alpine Global Management added most to People Inc in Q4 2019, an estimated $16.8M increase.
  • Alpine Global Management's biggest Q4 2019 reduction was Block Inc, cutting an estimated $19M.
  • Alpine Global Management fully exited Las Vegas Sands in Q4 2019, selling an estimated $120M.
  • Alpine Global Management's ten largest holdings make up 33% of its $469M portfolio in Q4 2019.
  • Alpine Global Management opened 384 new positions and closed 53 in Q4 2019.
  • Alpine Global Management's portfolio value rose 20% quarter-over-quarter to $469M.

Based on Alpine Global Management's 13F filing for Q4 2019, filed 16 Jan 2020.